COMPARATIVE ANALYSIS OF GABAPENTSAL AND GABAPENTIN INDUCED HISTOLOGICAL CHANGES IN LIVER AND KIDNEY TISSUES OF A MURINE EXPERIMENTAL MODEL
DOI:
https://doi.org/10.69723/njms.04.04.0679Keywords:
Neuropathic pain, Gabapentin, Schiff bases, Gabapentsal, Histological EffectsAbstract
ABSTRACT
ObjectivesGabapentin is widely used in the treatment of neuropathic diseases. Gabapentsal, a Schiff-based derivative of gabapentin, has diverse biological activities and a lower toxicity profile. This study aims to evaluate and compare the histological effects of gabapentsal and gabapentin on the liver and kidneys in a murine model.
Material and Methods
Thirty mice were divided into five groups, with six animals in each group. Group I (the control group) received normal saline. Groups II and III were treated with Gabapentin (2.5mg/kg and 5mg/kg respectively), while Groups IV and V were given Gabapentsal (2.5mg/kg and 5mg/kg respectively) via oral gavage for up to eight weeks. After the animals were anesthetized with chloral hydrate, liver and kidney tissues were collected for histological examination using H&E stain.
Results
Liver tissue from gabapentin-treated groups showed lobular cellular infiltration, dilatation of the central vein, severe inflammation in the portal/periportal area, hemorrhage, and distortion of hepatic architecture compared to the normal group. In contrast, the gabapentin-treated groups showed intact hepatic architecture, no changes in sinusoids or central vein but mild lobular and portal/periportal inflammation. The kidney tissue of the Gabapentin-treated groups showed severe dilatation of the glomeruli and blood vessels, and inflammatory cell infiltration, while the kidney tissue of Gabapentsal-treated mice showed mild architectural damage, dilated glomeruli and blood vessels, and inflammatory cell infiltration compared to the normal tissues.
Conclusion
Gabapentsal produces fewer toxic effects on kidney and liver tissue compared to Gabapentin-treated animals.
References
REFERENCES
1. Szewczyk AK, Jamroz-Wiśniewska A, Haratym N, Rejdak K. Neuropathic pain and chronic pain as an underestimated interdisciplinary problem. Int J Occup Med Environ Health. 2022;35(3):249–257. https://doi.org/10.13075/ijomeh.1896.01869
2. Baskozos G, Hébert HL, Pascal MM, Themistocleous AC, Macfarlane GJ, Wynick D, et al. Epidemiology of neuropathic pain: an analysis of prevalence and associated factors in UK Biobank. Pain Rep. 2023;8(2):e1066. https://doi.org/10.1097/PR9.0000000000001066
3. Hange N, Poudel S, Ozair S, Paul T, Nambakkam M, Shrestha R, et al. Managing chronic neuropathic pain: recent advances and new challenges. Neurol Res Int. 2022;2022:8336561. https://doi.org/10.1155/2022/8336561
4. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082–2097. https://doi.org/10.1016/S0140-6736(21)00393-7
5. Beghi E. The epidemiology of epilepsy. Neuroepidemiology. 2020;54(2):185–191. https://doi.org/10.1159/000503831
6. Smith BH, Hébert HL, Veluchamy A. Neuropathic pain in the community: prevalence, impact, and risk factors. Pain. 2020;161(Suppl 1):S127–S137. https://doi.org/10.1097/j.pain.0000000000001824
7. Nwankwo A, Koyyalagunta D, Huh B, D’Souza RS, Javed S. A comprehensive review of the typical and atypical side effects of gabapentin. Pain Pract. 2024;24(8):1051–1058. https://doi.org/10.1111/papr.13370
8. Abdulhussein AJ, Kahtan M, Fadhil AA. The effect of gabapentin on liver tissues and enzymes in rats. J Pharm Negat Results. 2022;13:1–7. https://doi.org/10.47750/pnr.2022.13.S03.001
9. Al-Zahid JM, Sharba IR, Ghani JM, Alshemkh M. Effects of gabapentin drug on hematological parameters and histological structures in female mice. Syst Rev Pharm. 2020;11(12):695–700.
10. Atrees SA, Rabie HM. Drug impairment and liver disease. Med J Cairo Univ. 2021;89:911–917.
11. Ismail OI, Shaltout ES, Abdellah NZ, Hetta DF, Abd El-Ghani WM, Abdelzaher LA, et al. The teratogenic effect of pregabalin on heart, liver and kidney in rats. BMC Pharmacol Toxicol. 2022;23(1):4. https://doi.org/10.1186/s40360-021-00546-2
12. Okail HA, El-Sayed MF, Adly MA, Abd Elsamei WM. Protective effects of melatonin and bee pollen on hematotoxicity and hepatorenal toxicity induced by long-term intake of gabapentin in female albino rats. Cell Biochem Biophys. 2025. https://doi.org/10.1007/s12013-025-01346-2
13. Ahmad N, Subhan F, Islam NU, Shahid M, Ullah N, Ullah R, et al. A novel gabapentin analogue assuages neuropathic pain response in chronic sciatic nerve constriction model in rats. Behav Brain Res. 2021;405:113190. https://doi.org/10.1016/j.bbr.2021.113190
14. Eckard ML, Kinsey SG. Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice. Neuropharmacology. 2021;190:108554. https://doi.org/10.1016/j.neuropharm.2021.108554
15. Scharf P, Rizzetto F, Xavier LF, Farsky SH. Xenobiotics delivered by electronic nicotine delivery systems: potential cellular and molecular mechanisms on the pathogenesis of chronic kidney disease. Int J Mol Sci. 2022;23(18):10293. https://doi.org/10.3390/ijms231810293
16. Scharf P, Rizzetto F, Xavier LF, Farsky SH. Xenobiotics delivered by electronic nicotine delivery systems: potential cellular and molecular mechanisms on the pathogenesis of chronic kidney disease. Int J Mol Sci. 2022;23(18):10293. https://doi.org/10.3390/ijms231810293
17. Shah A, Ali S, Badshah H, Abbas M, Nayab D, Shah WA. Evaluation of hepatoprotective potential of selected Schiff bases against gentamicin-induced hepatotoxicity. J Res Pharm. 2025;29(5):1878–1889. https://doi.org/10.12991/jrespharm.1763513
18. Atallah M, Sakr S, Badawy GM. Ginger extract as a potential therapeutic intervention for gabapentin-induced renal toxicity in chick embryos. Sci J Fac Sci Menoufia Univ. 2024;28(1):81–97.
19. Mahmood SS, Salah BA. The impact of two selected doses of gabapentin on the kidney and brain of adult white male rats: a histological, biochemical, and immunohistochemical study. Al-Kitab J Pure Sci. 2025;9(1):183–201.
20. Salman KH, Ali FA, Elhanbaly R. Effect of cultured white soft cheese on the histopathological changes in the kidneys and liver of albino rats. Sci Rep. 2022;12(1):2564. https://doi.org/10.1038/s41598-022-06564-6
21. Salah BA, Al-Fathi MY, Shindala MK. Histological liver, kidney, and brain changes induced by pregabalin drug in albino rats. Iraqi J Vet Sci. 2024;38(3):555–564.
22. Mohammed ZB, Omar TN, Mohammed Z. Chemical design, synthesis and biological evaluation of mutual prodrug of gabapentin with phenolic and alcoholic antioxidants. Syst Rev Pharm. 2021;12(1):858–868
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Hajra Ayub, Walayat Shah, Ikramullah, Hafiz Abdul Salam, Muhammad Ikram, Muhammad Saleh Faisal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purposes. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
.png)
